SCHEMBL30830385

SCHEMBL30830385

CS(=O)(=O)c1sc2cccnc2c1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 5/20 0.55
PARP1 P09874 1/20 0.39
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
KDM4E B2RXH2 3/20 0.36
CLK1 P49759 1/20 0.36
IKBKB O14920 2/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
CHUK O15111 1/20 0.35
ALOX5 P09917 1/20 0.35
HTT P42858 2/20 0.33
ALOX15 P16050 1/20 0.33
GLO1 Q04760 1/20 0.33
FTO Q9C0B1 1/20 0.33
HPGD P15428 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL30830333 0.99 LIMK1 (0.54) LIMK1PARP1PDE4APDE4BPDE4C
SCHEMBL5183670 0.79 LIMK1 (0.53) LIMK1KDM4ECLK1IKBKBCHUK
SCHEMBL5183472 0.76 LIMK1 (0.39) LIMK1KDM4ECLK1HTTALOX15
SCHEMBL5776212 0.73 LIMK1 (0.69) LIMK1PARP1KDM4ECLK1IKBKB
SCHEMBL21813696 0.72 LIMK1 (0.56) LIMK1PARP1KDM4ECLK1IKBKB
SCHEMBL10507045 0.69 LIMK1 (0.55) LIMK1KDM4ECLK1ALOX15FTO
SCHEMBL28717624 0.66 LIMK1 (0.47) LIMK1KDM4ECLK1ALOX15FTO
SCHEMBL8507168 0.65 LIMK1 (0.77) LIMK1PARP1KDM4ECLK1IKBKB
SCHEMBL22866720 0.65 KDM4E (0.48) LIMK1KDM4EHTTALOX15HPGD
SCHEMBL29560195 0.65 KDM4E (0.48) LIMK1KDM4EHTTALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240076301-A1 Solid Forms of an eIF4E Inhibitor OXFORD FINANCE LLC, AS COLLATERAL AGENT 2024-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240076301-A1 Solid Forms of an eIF4E Inhibitor EIF4E, EIF4EBP1, EIF4A1 LIMK1 1045/4885PARP1 922/4885PDE4A 2197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.